TRINITY MEDICAL GROUP INC
NT 10-Q, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: EROOM SYSTEM TECHNOLOGIES INC, 10QSB/A, 2000-08-14
Next: MICROWAVE TRANSMISSION SYSTEMS INC, 10QSB, 2000-08-14





                                  UNITED STATES              -----------------
                                                             SEC FILE NUMBER
                       SECURITIES AND EXCHANGE COMMISSION      000-30619
                                                             -----------------
                             WASHINGTON, D.C. 20549            CUSIP NUMBER
                                                                89652W103
                                   FORM 12B-25               -----------------

                           NOTIFICATION OF LATE FILING
(Check One): Form 10-K  Form 20-F   Form 11-K    XForm 10-Q        Form N-SAR

         For Period Ended:          August 14, 2000
                           ------------------------
   Transition Report on Form 10-K        Transition Report on Form 10-Q
   Transition Report on Form 20-F        Transition Report on Form N-SAR
   Transition Report on Form 11-K
   For the Transition Period Ended:
                                   ---------------------------------------------

  Read Instruction (on back page) Before Preparing Form. Please Print or Type.
    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                   VERIFIED ANY INFORMATION CONTAINED HEREIN.
--------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

                        PART I -- REGISTRANT INFORMATION

Trinity Medical Group USA, Inc.
--------------------------------------------------------------------------------
Full Name of Registrant

---------------------
Former Name if Applicable


3753 Howard Hughes Parkway, 2nd Floor
--------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Las Vegas, Nevada 94901
-------------------------
City, State and Zip Code

                       PART II -- RULES 12B-25(B) AND (C)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

         (a)  The reasons described in reasonable detail in Part III of this
              form could not be eliminated without unreasonable effort or
              expense;

         (b)  The subject annual report, semi-annual report, transition report
              on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof,
              will be filed on or before the fifteenth calendar day following
  [X]         the prescribed due date; or the subject quarterly report or
              transition report on Form 10-Q, or portion thereof will be filed
              on or before the fifth calendar day following the prescribed due
              date; and

         (c)  The accountant's statement or other exhibit required by Rule
              12b-25(c) has been attached if applicable.

                              PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.

                                SEE ATTACHMENT A


<PAGE>

                          PART IV -- OTHER INFORMATION


1.       Name and  telephone  number  of  person  to  contact  in regard to this
         notification

 Mr. James Namnath                            415                256-1995
 ----------------------------------- ---------------------  --------------------
                    (Name)                  (Area Code)       (Telephone Number)


2.       Have all other periodic  reports  required under Section 13 or 15(d) of
         the  Securities  Exchange  Act of 1934 or Section 30 of the  Investment
         Company  Act of 1940  during  the  preceding  12  months No or for such
         shorter  period that the registrant was required to file such report(s)
         been filed? If answer is no, identify report(s)   Yes     No
                                                           [ X ]  [  ]

3.       Is it anticipated that any significant  change in results of operations
         from  the  corresponding  period  for  the  last  fiscal  year  will be
         reflected by the earnings  statements  to be included in No the subject
         report or portion thereof?                         Yes    No
                                                           [ X ]  [  ]

         If  so,  attach  an  explanation  of  the  anticipated   change,   both
         narratively and quantitatively,  and, if appropriate, state the reasons
         why a reasonable estimate of results cannot be made.

--------------------------------------------------------------------------------

                         Trinity Medical Group USA, Inc.
--------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)



Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

                                          By: /s/ Dr. James S. Namnath
                                          ----------------------------
Date: August 11, 2000                     Name:    Dr. James S. Namnath
    -------------------------             Title:   Chief Executive Officer

         Instruction. The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.


<PAGE>


                                    ATTENTION

         Intentional  misstatements  or  omissions  of fact  constitute  Federal
criminal violations (see 18 U.S.C. 1001).


                              GENERAL INSTRUCTIONS

         1. This  form is  required  by Rule  12b-25  of the  General  Rules and
Regulations under the Securities Exchange Act of 1934.

         2. One signed original and four conformed copies of this form and
amendments thereto must be completed and filed with the Securities Exchange
Commission, Washington, DC 20549, in accordance with Rule 0-3 of the General
Rules and Regulations under the Act. The information contained in or filed with
the form will be made a matter of the public record in the Commission files.

         3. A manually signed copy of the form and amendments thereto shall be
filed with each national securities exchange on which any class of securities of
the registrant is registered.

         4. Amendments to the notifications must also be filed on Form 12b-25
but need not restate information that has been correctly furnished. The form
shall be clearly identified as an amended notification.

         5. Electronic Filers. This form shall not be used by electronic filers
unable to timely file a report solely due to electronic difficulties. Filers
unable to submit a report within the time period prescribed due to difficulties
in electronic filing should comply with either Rule 201 or Rule 202 of
Regulation S-T or apply for an adjustment in filing date pursuant to Rule 13(b)
of Regulation S-T.


<PAGE>


                                  ATTACHMENT A

                              PART III - NARRATIVE

The Registrant's Report on Form 10-Q for the period ended August 14, 2000 (the
"Report") could not be filed within the prescribed time period since the
Registrant, which has a small accounting staff, has devoted substantial time and
effort to recent business matters affecting the Registrant, thereby delaying
completion of the Report. As a result, the information necessary to complete the
Report, including the financial statements and the notes thereto, are in the
process of being completed.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission